Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Surgery. 2012 Jan 29;151(5):710–716. doi: 10.1016/j.surg.2011.12.017

Table 3.

Significant predictors of disease-free survival on univariate analysis (CR=complete response, PR=partial response, SD=stable disease, PD=progression of disease, ER=estrogen receptor)

Variable Disease-free survival (median,
mo)
P
All 14.2
Best RECIST response CR 18.5 vs. 4.1 0.02
Best RECIST response PR 31.1 vs. 6.4 <.001
Pre-operative RECIST response PR 48.8 vs. 8.5 .001
Pre-operative RECIST response--
PD versus PR or SD
6.4 vs. 26.3 .001
ER+ primary tumor 19.8 vs. 7.8 .031
Metastasis size >5cm 16.6 vs. 9.7 .023
Post-hepatectomy chemotherapy 20.7 vs. 12.2 .008